vs
三维系统(DDD)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是三维系统的1.9倍($197.9M vs $106.3M),REPLIGEN CORP净利率更高(6.7% vs -18.4%,领先25.1%),REPLIGEN CORP同比增速更快(13.6% vs -4.3%),REPLIGEN CORP自由现金流更多($17.6M vs $-16.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 1.6%)
3D Systems是一家总部位于美国南卡罗来纳州罗克希尔的企业,核心业务涵盖3D打印机、3D打印材料的研发生产与销售,同时提供3D打印零部件定制及应用工程服务,可产品概念模型、精密功能原型、工裝母模以及直接数字化生产零部件等产品,服务各行各业的数字化制造需求。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
DDD vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.9倍
$106.3M
营收增速更快
RGEN
高出17.9%
-4.3%
净利率更高
RGEN
高出25.1%
-18.4%
自由现金流更多
RGEN
多$34.2M
$-16.6M
两年增速更快
RGEN
近两年复合增速
1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $106.3M | $197.9M |
| 净利润 | $-19.5M | $13.3M |
| 毛利率 | 30.8% | 52.5% |
| 营业利润率 | -21.3% | 9.0% |
| 净利率 | -18.4% | 6.7% |
| 营收同比 | -4.3% | 13.6% |
| 净利润同比 | 41.7% | 143.9% |
| 每股收益(稀释后) | $0.04 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DDD
RGEN
| Q4 25 | $106.3M | $197.9M | ||
| Q3 25 | $91.2M | $188.8M | ||
| Q2 25 | $94.8M | $182.4M | ||
| Q1 25 | $94.5M | $169.2M | ||
| Q4 24 | $111.0M | $174.1M | ||
| Q3 24 | $112.9M | $154.9M | ||
| Q2 24 | $113.3M | $154.1M | ||
| Q1 24 | $102.9M | $151.3M |
净利润
DDD
RGEN
| Q4 25 | $-19.5M | $13.3M | ||
| Q3 25 | $-18.1M | $14.9M | ||
| Q2 25 | $104.4M | $14.9M | ||
| Q1 25 | $-37.0M | $5.8M | ||
| Q4 24 | $-33.5M | $-30.3M | ||
| Q3 24 | $-178.6M | $-654.0K | ||
| Q2 24 | $-27.3M | $3.3M | ||
| Q1 24 | $-16.0M | $2.1M |
毛利率
DDD
RGEN
| Q4 25 | 30.8% | 52.5% | ||
| Q3 25 | 32.3% | 53.2% | ||
| Q2 25 | 38.1% | 50.0% | ||
| Q1 25 | 34.6% | 53.6% | ||
| Q4 24 | 31.0% | 26.1% | ||
| Q3 24 | 36.9% | 50.0% | ||
| Q2 24 | 41.6% | 49.8% | ||
| Q1 24 | 39.8% | 49.5% |
营业利润率
DDD
RGEN
| Q4 25 | -21.3% | 9.0% | ||
| Q3 25 | -23.4% | 8.9% | ||
| Q2 25 | -16.2% | 7.6% | ||
| Q1 25 | -38.9% | 3.9% | ||
| Q4 24 | -27.4% | -17.7% | ||
| Q3 24 | -160.0% | -5.1% | ||
| Q2 24 | -23.3% | 1.0% | ||
| Q1 24 | -38.7% | 1.3% |
净利率
DDD
RGEN
| Q4 25 | -18.4% | 6.7% | ||
| Q3 25 | -19.8% | 7.9% | ||
| Q2 25 | 110.1% | 8.2% | ||
| Q1 25 | -39.1% | 3.4% | ||
| Q4 24 | -30.1% | -17.4% | ||
| Q3 24 | -158.2% | -0.4% | ||
| Q2 24 | -24.1% | 2.2% | ||
| Q1 24 | -15.5% | 1.4% |
每股收益(稀释后)
DDD
RGEN
| Q4 25 | $0.04 | $0.24 | ||
| Q3 25 | $-0.14 | $0.26 | ||
| Q2 25 | $0.57 | $0.26 | ||
| Q1 25 | $-0.28 | $0.10 | ||
| Q4 24 | $-0.26 | $-0.55 | ||
| Q3 24 | $-1.35 | $-0.01 | ||
| Q2 24 | $-0.21 | $0.06 | ||
| Q1 24 | $-0.12 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $95.6M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $240.4M | $2.1B |
| 总资产 | $521.7M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
DDD
RGEN
| Q4 25 | $95.6M | $767.6M | ||
| Q3 25 | $95.5M | $748.7M | ||
| Q2 25 | $116.4M | $708.9M | ||
| Q1 25 | $135.0M | $697.2M | ||
| Q4 24 | $171.3M | $757.4M | ||
| Q3 24 | $190.0M | $784.0M | ||
| Q2 24 | $192.7M | $809.1M | ||
| Q1 24 | $212.0M | $780.6M |
总债务
DDD
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
DDD
RGEN
| Q4 25 | $240.4M | $2.1B | ||
| Q3 25 | $221.1M | $2.1B | ||
| Q2 25 | $241.2M | $2.1B | ||
| Q1 25 | $145.6M | $2.0B | ||
| Q4 24 | $176.2M | $2.0B | ||
| Q3 24 | $218.0M | $2.0B | ||
| Q2 24 | $381.7M | $2.0B | ||
| Q1 24 | $408.4M | $2.0B |
总资产
DDD
RGEN
| Q4 25 | $521.7M | $2.9B | ||
| Q3 25 | $554.5M | $2.9B | ||
| Q2 25 | $587.8M | $2.9B | ||
| Q1 25 | $583.4M | $2.9B | ||
| Q4 24 | $608.8M | $2.8B | ||
| Q3 24 | $658.3M | $2.8B | ||
| Q2 24 | $821.5M | $2.9B | ||
| Q1 24 | $857.2M | $2.8B |
负债/权益比
DDD
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-14.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-16.6M | $17.6M |
| 自由现金流率自由现金流/营收 | -15.7% | 8.9% |
| 资本支出强度资本支出/营收 | 1.8% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-97.8M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
DDD
RGEN
| Q4 25 | $-14.7M | $25.7M | ||
| Q3 25 | $-13.5M | $48.1M | ||
| Q2 25 | $-25.8M | $28.6M | ||
| Q1 25 | $-33.8M | $15.0M | ||
| Q4 24 | $-7.8M | $39.2M | ||
| Q3 24 | $-801.0K | $49.3M | ||
| Q2 24 | $-10.8M | $42.2M | ||
| Q1 24 | $-25.5M | $44.7M |
自由现金流
DDD
RGEN
| Q4 25 | $-16.6M | $17.6M | ||
| Q3 25 | $-15.8M | $43.4M | ||
| Q2 25 | $-28.8M | $21.5M | ||
| Q1 25 | $-36.6M | $11.4M | ||
| Q4 24 | $-13.1M | $33.6M | ||
| Q3 24 | $-4.4M | $42.3M | ||
| Q2 24 | $-14.7M | $37.4M | ||
| Q1 24 | $-28.7M | $36.4M |
自由现金流率
DDD
RGEN
| Q4 25 | -15.7% | 8.9% | ||
| Q3 25 | -17.3% | 23.0% | ||
| Q2 25 | -30.4% | 11.8% | ||
| Q1 25 | -38.7% | 6.8% | ||
| Q4 24 | -11.8% | 19.3% | ||
| Q3 24 | -3.9% | 27.3% | ||
| Q2 24 | -13.0% | 24.3% | ||
| Q1 24 | -27.9% | 24.0% |
资本支出强度
DDD
RGEN
| Q4 25 | 1.8% | 4.1% | ||
| Q3 25 | 2.5% | 2.5% | ||
| Q2 25 | 3.1% | 3.9% | ||
| Q1 25 | 3.0% | 2.1% | ||
| Q4 24 | 4.8% | 3.2% | ||
| Q3 24 | 3.2% | 4.5% | ||
| Q2 24 | 3.5% | 3.1% | ||
| Q1 24 | 3.1% | 5.5% |
现金转化率
DDD
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | -0.25× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DDD
| Products | $62.6M | 59% |
| Services | $43.7M | 41% |
RGEN
暂无分部数据